TGS Baltic has advised two of Kilo Health's shareholders on selling a minority stake in the company to Scandinavian and Estonian funds.
Kilo Health is a digital health and wellness company. According to TGS Baltic, “since June, the Danish fund Nordic Secondary Fund II and the Finnish fund First Fellow have become the shareholders of Kilo Grupe. Estonian funds Usaldusfond Specialist VC Primary and Secondary Fund II, Metaplanet Holdings, and Biofuel become the shareholders of the group in May. A small part of the company’s shares was sold to the mentioned funds. After the transaction, there will be no changes in the company’s management.”
In 2021, TGS Baltic also advised Kilo Health on its investment in Revolab (as reported by CEE Legal Matters on June 21, 2021).
TGS Baltic’s team included Executive Partner Marius Matonis and Senior Associate Ruta Tikuisyte.
TGS Baltic did not respond to our inquiry on the matter.
